Article Text

Download PDFPDF
A new cell line from a recurrent conjunctival melanoma
  1. Sander Keijser,
  2. Willem Maat,
  3. Guy S Missotten,
  4. Rob J W de Keizer
  1. Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands
  1. Professor R J W de Keizer, Department of Ophthalmology, Leiden University Medical Center, PO Box 9600, 2300 RC, Leiden, the Netherlands; r.j.w.de_keizer{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The incidence of conjunctival melanoma is about 0.2–0.8/1 000 000 cases each year.1 2 As a consequence our knowledge about this tumour is limited, but cell lines derived from these tumours will give more information about them. So far only three conjunctival melanoma cell lines have been described.3 4 The first cell line, IPC 292, was described in 1993 by Aubert et al.4 Recently, Nareyeck et al developed two additional conjunctival melanoma cell lines (CRMM1 and CRMM2).3 We wish to report a further, fourth, conjunctival melanoma cell line, CM2005.1.

The conjunctival melanoma cell line CM2005.1 was established from tumour material derived from a 84-year-old male. The primary tumour was located at the medial side of the inner …

View Full Text


  • Competing interests: None declared.

  • Funding: None.